Description and Bacteriological Characteristics of the Cases of Epiglottitis
| Studied Period . | Total No. of Cases . | No. of Epiglottitis Cases (%) . | Cases . | Age, y . | Year . | Sex . | Site . | Group . | Clonal Complex . | MIC Penicillin Ga . | MIC Cefotaximb . |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015 to March 15, 2020 | 2211 | 5 (0.2) | 1 | 42.14 | 2017 | M | Blood | W | 11 | 0.032(S) | 0.003 (S) |
| 2 | 87.74 | 2017 | F | Blood | W | 11 | 0.032 (S) | 0.002 (S) | |||
| 3 | 82.25 | 2018 | F | Blood | C | 11 | 0.047 (S) | 0.004 (S) | |||
| 4 | 80.12 | 2019 | F | Blood | Y | 23 | 0.064 (S) | 0.004 (S) | |||
| 5 | 72.54 | 2019 | F | Blood | C | 11 | 0.064 (S) | 0.006 (S) | |||
| March 16, 2020–September 2022 | 345 | 0 (0) | |||||||||
| October 2022–June 2023 | 465 | 8 (1.7) | 6 | 52.94 | Oct. 2022 | F | Blood | W | 22 | 0.19 (I) | 0.006 (S) |
| 7 | 79.68 | Dec. 2022 | F | Blood | W | 11 | 0.047 (S) | 0.003 (S) | |||
| 8 | 82.88 | 2023 | M | Blood | W | 11 | 0.094 (S) | 0.006 (S) | |||
| 9 | 86.48 | 2023 | F | Blood | Y | 23 | 0.19 (I) | 0.008 (S) | |||
| 10 | 66.87 | 2023 | F | Blood | W | 11 | 0.125 (I) | 0.012 (S) | |||
| 11 | 84.39 | 2023 | F | Blood | W | 11 | 0.094 (S) | 0.012 (S) | |||
| 12 | 74.35 | 2023 | M | Blood | Y | 23 | 0.19 (I) | 0.012 (S) | |||
| 13 | 69.77 | 2023 | F | Blood | W | 11 | 0.047 (S) | 0.004 (S) |
| Studied Period . | Total No. of Cases . | No. of Epiglottitis Cases (%) . | Cases . | Age, y . | Year . | Sex . | Site . | Group . | Clonal Complex . | MIC Penicillin Ga . | MIC Cefotaximb . |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015 to March 15, 2020 | 2211 | 5 (0.2) | 1 | 42.14 | 2017 | M | Blood | W | 11 | 0.032(S) | 0.003 (S) |
| 2 | 87.74 | 2017 | F | Blood | W | 11 | 0.032 (S) | 0.002 (S) | |||
| 3 | 82.25 | 2018 | F | Blood | C | 11 | 0.047 (S) | 0.004 (S) | |||
| 4 | 80.12 | 2019 | F | Blood | Y | 23 | 0.064 (S) | 0.004 (S) | |||
| 5 | 72.54 | 2019 | F | Blood | C | 11 | 0.064 (S) | 0.006 (S) | |||
| March 16, 2020–September 2022 | 345 | 0 (0) | |||||||||
| October 2022–June 2023 | 465 | 8 (1.7) | 6 | 52.94 | Oct. 2022 | F | Blood | W | 22 | 0.19 (I) | 0.006 (S) |
| 7 | 79.68 | Dec. 2022 | F | Blood | W | 11 | 0.047 (S) | 0.003 (S) | |||
| 8 | 82.88 | 2023 | M | Blood | W | 11 | 0.094 (S) | 0.006 (S) | |||
| 9 | 86.48 | 2023 | F | Blood | Y | 23 | 0.19 (I) | 0.008 (S) | |||
| 10 | 66.87 | 2023 | F | Blood | W | 11 | 0.125 (I) | 0.012 (S) | |||
| 11 | 84.39 | 2023 | F | Blood | W | 11 | 0.094 (S) | 0.012 (S) | |||
| 12 | 74.35 | 2023 | M | Blood | Y | 23 | 0.19 (I) | 0.012 (S) | |||
| 13 | 69.77 | 2023 | F | Blood | W | 11 | 0.047 (S) | 0.004 (S) |
Abbreviations: I, intermediate; MIC, minimal inhibitory concentration; S, susceptible.
aMIC for penicillin G < 0.125 mg/L for S and ≥ for I.
bMIC for cefotaxim ≤0.125 mg/L for S.
Description and Bacteriological Characteristics of the Cases of Epiglottitis
| Studied Period . | Total No. of Cases . | No. of Epiglottitis Cases (%) . | Cases . | Age, y . | Year . | Sex . | Site . | Group . | Clonal Complex . | MIC Penicillin Ga . | MIC Cefotaximb . |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015 to March 15, 2020 | 2211 | 5 (0.2) | 1 | 42.14 | 2017 | M | Blood | W | 11 | 0.032(S) | 0.003 (S) |
| 2 | 87.74 | 2017 | F | Blood | W | 11 | 0.032 (S) | 0.002 (S) | |||
| 3 | 82.25 | 2018 | F | Blood | C | 11 | 0.047 (S) | 0.004 (S) | |||
| 4 | 80.12 | 2019 | F | Blood | Y | 23 | 0.064 (S) | 0.004 (S) | |||
| 5 | 72.54 | 2019 | F | Blood | C | 11 | 0.064 (S) | 0.006 (S) | |||
| March 16, 2020–September 2022 | 345 | 0 (0) | |||||||||
| October 2022–June 2023 | 465 | 8 (1.7) | 6 | 52.94 | Oct. 2022 | F | Blood | W | 22 | 0.19 (I) | 0.006 (S) |
| 7 | 79.68 | Dec. 2022 | F | Blood | W | 11 | 0.047 (S) | 0.003 (S) | |||
| 8 | 82.88 | 2023 | M | Blood | W | 11 | 0.094 (S) | 0.006 (S) | |||
| 9 | 86.48 | 2023 | F | Blood | Y | 23 | 0.19 (I) | 0.008 (S) | |||
| 10 | 66.87 | 2023 | F | Blood | W | 11 | 0.125 (I) | 0.012 (S) | |||
| 11 | 84.39 | 2023 | F | Blood | W | 11 | 0.094 (S) | 0.012 (S) | |||
| 12 | 74.35 | 2023 | M | Blood | Y | 23 | 0.19 (I) | 0.012 (S) | |||
| 13 | 69.77 | 2023 | F | Blood | W | 11 | 0.047 (S) | 0.004 (S) |
| Studied Period . | Total No. of Cases . | No. of Epiglottitis Cases (%) . | Cases . | Age, y . | Year . | Sex . | Site . | Group . | Clonal Complex . | MIC Penicillin Ga . | MIC Cefotaximb . |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015 to March 15, 2020 | 2211 | 5 (0.2) | 1 | 42.14 | 2017 | M | Blood | W | 11 | 0.032(S) | 0.003 (S) |
| 2 | 87.74 | 2017 | F | Blood | W | 11 | 0.032 (S) | 0.002 (S) | |||
| 3 | 82.25 | 2018 | F | Blood | C | 11 | 0.047 (S) | 0.004 (S) | |||
| 4 | 80.12 | 2019 | F | Blood | Y | 23 | 0.064 (S) | 0.004 (S) | |||
| 5 | 72.54 | 2019 | F | Blood | C | 11 | 0.064 (S) | 0.006 (S) | |||
| March 16, 2020–September 2022 | 345 | 0 (0) | |||||||||
| October 2022–June 2023 | 465 | 8 (1.7) | 6 | 52.94 | Oct. 2022 | F | Blood | W | 22 | 0.19 (I) | 0.006 (S) |
| 7 | 79.68 | Dec. 2022 | F | Blood | W | 11 | 0.047 (S) | 0.003 (S) | |||
| 8 | 82.88 | 2023 | M | Blood | W | 11 | 0.094 (S) | 0.006 (S) | |||
| 9 | 86.48 | 2023 | F | Blood | Y | 23 | 0.19 (I) | 0.008 (S) | |||
| 10 | 66.87 | 2023 | F | Blood | W | 11 | 0.125 (I) | 0.012 (S) | |||
| 11 | 84.39 | 2023 | F | Blood | W | 11 | 0.094 (S) | 0.012 (S) | |||
| 12 | 74.35 | 2023 | M | Blood | Y | 23 | 0.19 (I) | 0.012 (S) | |||
| 13 | 69.77 | 2023 | F | Blood | W | 11 | 0.047 (S) | 0.004 (S) |
Abbreviations: I, intermediate; MIC, minimal inhibitory concentration; S, susceptible.
aMIC for penicillin G < 0.125 mg/L for S and ≥ for I.
bMIC for cefotaxim ≤0.125 mg/L for S.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
